Schoenhaus v. Genesco, Inc.

351 F. Supp. 2d 320, 2005 U.S. Dist. LEXIS 243, 2005 WL 41250
CourtDistrict Court, E.D. Pennsylvania
DecidedJanuary 10, 2005
DocketCIV.A. 03-0372
StatusPublished
Cited by1 cases

This text of 351 F. Supp. 2d 320 (Schoenhaus v. Genesco, Inc.) is published on Counsel Stack Legal Research, covering District Court, E.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Schoenhaus v. Genesco, Inc., 351 F. Supp. 2d 320, 2005 U.S. Dist. LEXIS 243, 2005 WL 41250 (E.D. Pa. 2005).

Opinion

OPINION

POLLAK, District Judge.

Plaintiffs Harold Schoenhaus and Richard M. Jay have filed suit against Genes-co and Johnston & Murphy (collectively referred to as “Genesco”). 1 Count I claims infringement of plaintiffs’ patent for an orthotic device designed to prevent hyperpronation of the foot; Count II alleges misappropriation of trade secrets; Count III alleges conversion; and Count IV alleges unjust enrichment. Taken collectively, Counts II, III, and IV charge misappropriation, and impermissible exploitation, of the trade secrets allegedly embodied in plaintiffs’ patent.

Currently before the court is defendants’ motion for summary judgment with respect to Count I of plaintiffs’ complaint. Defendants argue in their summary judgment motion (1) that their products do not infringe upon plaintiffs’ patent, and, in the alternative, (2) that plaintiffs’ patent is invalid. For the reasons set forth below, the court finds that plaintiffs cannot prevail on their claim of infringement. Since the finding of non-infringement suffices to establish that defendants’ motion for summary judgment on Count I should be granted, it will not be necessary to address defendants’ claim that the patent is invalid.

I. Background

Plaintiffs, both doctors of podiatry, hold a patent for a Dynamic Stabilizing Inner *322 Sole System (DSIS), an “orthotic device for preventing hyperpronation of a human foot [that] has a deep heel seat to cup the calcaneus and maintain it in approximately 5 degrees of varus, and high medial and lateral flanges which prevent lateral transverse drift of the first and fifth metatarsals.” 2 U.S. Patent No. 5,174,052 (issued Dec. 29, 1992) (“The ’052 patent”). Plaintiffs filed their patent application on January 3, 1991, and it was granted on December 29,1992.

Shortly after filing their application for the >052 patent, plaintiffs contacted defendants to see if defendants would be interested in licensing the DSIS- On January 29, 1992, Fowler, Low, Johnston & Murphy’s Chairman and CEO, signed a Confidential Non-Disclosure Agreement on behalf of Genesco according to which plaintiffs would provide defendants with information about their invention so that defendants could fully evaluate the feasibility and profitability of licensing DSIS. In consideration thereof, plaintiffs agreed to give Genesco exclusive rights to the licensing of DSIS for three years.

Negotiations between the parties continued through July 1994. Over this two- and-a-half year period, defendants’ representatives met with plaintiffs five times. In April 1992, defendants made a prototype shoe with advice and consultation from the plaintiffs. Between December 1993 and July 1994, the parties exchanged draft license agreements. On July 7,1994, defendants sent plaintiffs a letter stating that, in light of the continued failure of the two parties to agree on licensing terms, defendants would withdraw from the negotiations.

In the winter of 2002, Dr. Schoenhaus entered a Johnston & Murphy store and saw shoes that appeared (to him, at least) to copy plaintiffs’ invention. This suit for patent infringement followed.

II. Discussion

a. Standard of Review

The standard according to which each party’s arguments are assessed flows both from the general constraints on the granting of summary judgment motions and from the increased stringency with which such motions are reviewed in the patent litigation context. In general, summary judgment is available only when no genuine issue of material fact exists. Fed. R. Civ. Proc. 56(c). An issue is genuine where the “evidence is such that a reasonable jury could return a verdict for the nonmoving party.” Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 248, 106 S.Ct. 2505, 91 L.Ed.2d 202 (1986). A fact is material if it might affect the outcome of the suit under the governing law. Id. On a summary judgment motion claiming non-infringement, then, summary judgment in favor of the defendant is appropriate only “when no reasonable jury could find that every limitation recited in the properly construed claim [] is [] found in the ac *323 cused device.” Int’l Rectifier Corp. v. IXYS Corp., 361 F.3d 1363, 1369 (Fed.Cir. 2004) (internal citation omitted).

The moving party — defendants, in this case — bears the burden of establishing that there is no genuine issue of material fact, see, e.g., Adickes v. S.H. Kress & Co., 398 U.S. 144, 157, 90 S.Ct. 1598, 26 L.Ed.2d 142 (1970), and the evidence is construed in favor of the non-moving party, see, e.g., Int’l Rectifier Corp., 361 F.3d at 1369. Nonetheless, the non-moving party cannot defeat a summary judgment motion simply by alleging facts contrary to those that the moving party advances; instead, the non-moving party must support its allegations with affidavits or other evidence. See, e.g., Crown Operations Int’l, Ltd. v. Solutia Inc., 289 F.3d 1367, 1375 (Fed.Cir.2002); Barmag Barmer Maschinenfabrik AG v. Murata Machinery, Ltd., 731 F.2d 831, 835-836 (Fed.Cir.1984);.

While “[sjummary judgment is as appropriate in a patent case as in any other,” 731 F.2d at 835, demonstrating entitlement to summary judgment in a patent case tends to be particularly difficult because patent disputes are generally very fact intensive, see, e.g., Continuous Curve Contact Lenses, Inc. v. Rynco Scientific Corp., 680 F.2d 605, 606 (9th Cir.1982) (“Patent claims are ones in which issues of fact often dominate the scene and summary judgment is allowed only with great caution”) (internal citations omitted).

b. Claim Construction

The first step in analyzing either a non-infringement or an invalidity claim is to provide a construction of the patent claims. See, e.g., Dayco Prods, v. Total Containment, Inc., 258 F.3d 1317, 1324 (Fed.Cir.2001) (stating that patent infringement analysis requires two steps B first, construction of the patent and, second, application of that construction to the accused product); Amazon.com, Inc. v. Barnesandnoble.com, Inc., 239 F.3d 1343

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Schoenhaus v. Genesco, Inc.
440 F.3d 1354 (Federal Circuit, 2006)

Cite This Page — Counsel Stack

Bluebook (online)
351 F. Supp. 2d 320, 2005 U.S. Dist. LEXIS 243, 2005 WL 41250, Counsel Stack Legal Research, https://law.counselstack.com/opinion/schoenhaus-v-genesco-inc-paed-2005.